SEC 13F Intelligence

Brandywine Global Investment Management, LLC / REGN

Brandywine Global Investment Management, LLC’s Regeneron Pharmaceuticals Position

Does Brandywine Global Investment Management, LLC own Regeneron Pharmaceuticals (REGN)? Yes — 23.1K shares worth $18M (+0.12% of its 13F portfolio) as of Q4 2025, down from 95.7K shares the prior filed quarter.

Position Value
$18M
Q4 2025
Shares
23.1K
% of Portfolio
+0.12%
Quarters Held
11
currently held

Position History REGN

Reported value by quarter
Q3 ’20: $9MQ3 ’20Q4 ’20: $60MQ1 ’21: $27MQ1 ’21Q2 ’21: $38MQ3 ’21: $65MQ3 ’21Q4 ’21: $61MQ1 ’22: $65MQ1 ’22Q2 ’22: $53MQ3 ’22: $60MQ3 ’22Q4 ’22: $69MQ4 ’25: $18MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202523.1K$18M+0.12%
Q4 202295.7K$69M+0.54%
Q3 202287.5K$60M+0.56%
Q2 202289.8K$53M+0.46%
Q1 202293.3K$65M+0.48%
Q4 202196.7K$61M+0.44%
Q3 2021107.3K$65M+0.49%
Q2 202168.2K$38M+0.28%
Q1 202157.4K$27M+0.20%
Q4 2020124.0K$60M+0.50%
Q3 202016.0K$9M+0.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Brandywine Global Investment Management, LLC’s full portfolio or all institutional holders of REGN.